As EPCs express the LPS receptors CD14 and toll-like receptor-2 (TLR-2) [23], we tested whether challenging EPCs isolated from DM-CAD subjects with LPS resulted in upregulation of bone-related markers. The gene discussed is IRF6; the disease is diabetes mellitus.